Showing 61 - 70 of 212,529
Pharmaceuticals in the Environment: Regulatory and Nonregulatory Approaches -- Current Findings -- Regulatory Options …
Persistent link: https://www.econbiz.de/10012685632
External reference pricing (ERP), the practice of benchmarking domestic drug prices to foreign prices, generates an incentive for firms to withhold products from low-income countries. Using a novel moment inequality approach, we estimate a structural model to measure the extent to which ERP...
Persistent link: https://www.econbiz.de/10014093683
The article deals with the intersection between competition law rules on abuse of a dominant position and switching strategies employed by pharmaceutical originator companies. Switching is also known as ever-greening, product hopping or product life cycle strategies. It is one of the most...
Persistent link: https://www.econbiz.de/10013077034
Pharmaceuticals are chemicals that are used because of their biological activity. They are often excreted unchanged and … transformation products resulting from the parent APIs is not yet known. Awareness of the presence of pharmaceuticals in the … pharmaceuticals to the environment should be considered. As for effluent treatment, no technology works well for all compounds …
Persistent link: https://www.econbiz.de/10013210298
Persistent link: https://www.econbiz.de/10014314376
to health care, including pharmaceuticals. Given pressure on public budgets and rising expenditure for healthcare …, national governments have introduced mechanisms to regulate healthcare services provision and set prices of pharmaceuticals. As … pharmaceuticals and, in particular, its price-setting system. The bill endorsed by the German parliament in late 2010 will …
Persistent link: https://www.econbiz.de/10013018181
Persistent link: https://www.econbiz.de/10014432663
Persistent link: https://www.econbiz.de/10002946295